Mouritzen, M.T. et al. 2022. Clinical features affecting efficacy of immune checkpoint inhibitors in pretreated patients with advanced NSCLC: a Danish nationwide real-world study. Acta Oncologica. 61, 4 (Apr. 2022), 409–416. DOI:https://doi.org/10.1080/0284186X.2021.2023213.